Mitochondrial dysfunction and serum lactate as a biomarker for the progression and disability in MS and its correlation with the radiological findings
Publication type: Journal Article
Publication date: 2021-03-04
scimago Q2
wos Q4
SJR: 0.549
CiteScore: 3.4
Impact factor: 1.5
ISSN: 01616412, 17431328
PubMed ID:
33657991
General Medicine
Neurology
Neurology (clinical)
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
Antioxidants
1 publication, 7.69%
|
|
|
International Journal of Molecular Sciences
1 publication, 7.69%
|
|
|
Developmental Cell
1 publication, 7.69%
|
|
|
Journal of Neuroinflammation
1 publication, 7.69%
|
|
|
Journal of Oral Microbiology
1 publication, 7.69%
|
|
|
PLoS ONE
1 publication, 7.69%
|
|
|
Cell Metabolism
1 publication, 7.69%
|
|
|
Neuroscience and Biobehavioral Reviews
1 publication, 7.69%
|
|
|
Current Treatment Options in Neurology
1 publication, 7.69%
|
|
|
Mitochondrion
1 publication, 7.69%
|
|
|
Frontiers in Aging
1 publication, 7.69%
|
|
|
Scientific Reports
1 publication, 7.69%
|
|
|
Frontiers in Microbiology
1 publication, 7.69%
|
|
|
1
|
Publishers
|
1
2
3
4
|
|
|
Elsevier
4 publications, 30.77%
|
|
|
Springer Nature
3 publications, 23.08%
|
|
|
MDPI
2 publications, 15.38%
|
|
|
Frontiers Media S.A.
2 publications, 15.38%
|
|
|
Taylor & Francis
1 publication, 7.69%
|
|
|
Public Library of Science (PLoS)
1 publication, 7.69%
|
|
|
1
2
3
4
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
13
Total citations:
13
Citations from 2024:
10
(76.92%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Esmael A. et al. Mitochondrial dysfunction and serum lactate as a biomarker for the progression and disability in MS and its correlation with the radiological findings // Neurological Research. 2021. Vol. 43. No. 7. pp. 582-590.
GOST all authors (up to 50)
Copy
Esmael A., Talaat M., Egila H., Eltoukhy K. Mitochondrial dysfunction and serum lactate as a biomarker for the progression and disability in MS and its correlation with the radiological findings // Neurological Research. 2021. Vol. 43. No. 7. pp. 582-590.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1080/01616412.2021.1893567
UR - https://doi.org/10.1080/01616412.2021.1893567
TI - Mitochondrial dysfunction and serum lactate as a biomarker for the progression and disability in MS and its correlation with the radiological findings
T2 - Neurological Research
AU - Esmael, A.
AU - Talaat, Mona
AU - Egila, Hosam
AU - Eltoukhy, Khaled
PY - 2021
DA - 2021/03/04
PB - Taylor & Francis
SP - 582-590
IS - 7
VL - 43
PMID - 33657991
SN - 0161-6412
SN - 1743-1328
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Esmael,
author = {A. Esmael and Mona Talaat and Hosam Egila and Khaled Eltoukhy},
title = {Mitochondrial dysfunction and serum lactate as a biomarker for the progression and disability in MS and its correlation with the radiological findings},
journal = {Neurological Research},
year = {2021},
volume = {43},
publisher = {Taylor & Francis},
month = {mar},
url = {https://doi.org/10.1080/01616412.2021.1893567},
number = {7},
pages = {582--590},
doi = {10.1080/01616412.2021.1893567}
}
Cite this
MLA
Copy
Esmael, A., et al. “Mitochondrial dysfunction and serum lactate as a biomarker for the progression and disability in MS and its correlation with the radiological findings.” Neurological Research, vol. 43, no. 7, Mar. 2021, pp. 582-590. https://doi.org/10.1080/01616412.2021.1893567.